PROFESSIONAL EDITION

The largest community of pharma leaders

Biotechnology

      New Strategic Vision for Biotechnology Innovation Organization

      WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness...

      Goldfinch Bio Presents Clinical Data from Phase 1 Trial Supporting Advancement of GFB-887 as a Precision Medicine for Patients with Kidney Diseases

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced...

      Confo Therapeutics Announces Selection of First Product Candidate and Initiation of Pre-Clinical Development

      GHENT, Belgium--(BUSINESS WIRE)--Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with...

      Transgene and BioInvent to Present Data on Oncolytic Virus BT-001 at the SITC 35th Anniversary Annual Meeting

      STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

      BryoLogyx Announces Completion of World’s First GMP Synthesis of Bryostatin-1

      DANVILLE, Calif.--(BUSINESS WIRE)--BryoLogyx, Inc., today announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations. Bryostatin-1...

      Recent Articles